Skip to main content
. 2020 Apr 30;6(3):178–184. doi: 10.1002/cjp2.165

Table 2.

12q15 (MDM2) amplification status of mesenchymal uterine neoplasms including LGESS, HGESS‐BCOR, HGESS with YWHAE‐rearrangement, UTROSCT, ULM, and ULMS

Diagnosis 12q15 amplification (MDM2)
Low‐grade endometrial stromal sarcoma 0/17 (0%)
High‐grade endometrial stromal sarcoma (BCOR) 5/5 (100%)
High‐grade endometrial stromal sarcoma (YWHAE‐NUTM2) 0/6 (0%)
Uterine tumor resembling ovarian sex cord tumor 0/15 (0%)
Uterine leiomyoma 0/8 (0%)
Uterine leiomyosarcoma 0/7 (0%)